This metabolic reprogramming not only supports the rapid proliferation and invasive ability of tumor cells, but also achieves the evasion of immune surveillance by inhibiting the activity and cytotoxicity of CD8+ T cells (Jiang J. et al., 2025). This evidence concerns the gene CD8A and neoplasm.